Conversely, the Tie2+CD11b+ population decreased in the tumor of these mice at the end of treatment (p = 0.055), and a trend was observed for the VEGFR-1+CD11b+ population (Figure 7C,D). The gene discussed is FLT1; the disease is neoplasm.